Depressive disorder. Mood [affective] disorders
Conditions
Interventions
Intervention 1: Group 1: patients in group 1 will receive Lorazepam 1mg per night for 4 week. Intervention 2: Group 2: patients in group 2 will receive sleep healthy education face to face training
Treatment - Drugs
Treatment - Other
Group 1: patients in group 1 will receive Lorazepam 1mg per night for 4 week.
Group 2: patients in group 2 will receive sleep healthy education face to face training and pamphlets.
Group 3: patients in group 3 will receive sleep healthy education face to face training and pamphlets and Lorazepam 1mg per night for 4 week.
Sponsors
Vice chancellor for research, Hamadan university of medical sciences
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Middle age group (35-60? No history of psychiatric disorders associated? No history of serious physical illness? Treated with SSRI antidepressants? The ability to read and write. Exclusion criteria included Electroconvulsive therapy? Having physical pain from chronic diseases? History of substance abuse.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep disorders. Timepoint: Before and 4 week after. Method of measurement: Sleep Disorders Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depressive level. Timepoint: Before and four weeks after. Method of measurement: Hamilton Depression Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarshid Shamsaei
Hamadan university of medical sciences
Outcome results
None listed